Federal Grants for Food and Nutrition



Department of Health and Human Services
 $62,853,680,968 Department of Transportation
 $56,443,571,981 Environmental Protection Agency
 $35,751,587,496 Department of Energy
 $24,661,368,000 National Aeronautics and Space Administration
 $14,032,768,821 Department of Homeland Security
 $13,986,266,741 Department of Labor
 $10,348,285,755 Department of Defense
 $10,111,366,675 Department of the Interior
 $9,806,569,960 Department of Agriculture
 $8,296,397,040 Agency for International Development
 $7,754,781,106 Department of Commerce
 $6,871,103,950 Department of Housing and Urban Development
 $6,642,477,476 Department of State
 $6,042,666,916 Department of Justice
 $5,571,395,802 Department of Education
 $2,642,831,221 Department of the Treasury
 $1,019,380,000 Other Agencies
 $724,036,487


Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Food and Drug Administration
An estimated 1.7 million Americans aged 12 and older used kratom in 2021, according to the Substance Abuse and Mental Health Services Administration’s National Survey on Drug Use and Health....more
Posted On - 2024-01-16


Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Food and Drug Administration
Complex generic drug products represent an increasing share of the generic marketplace and may have distinct user interface differences compared to reference listed drug (RLD) products. A modernized...more
Posted On - 2024-01-15


Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Food and Drug Administration
The objective of this research proposal is to develop physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro in vivo correlations (IVIVCs) for two major types of long acting...more
Posted On - 2024-01-15




Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

Food and Drug Administration
The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., quantitative tomography-based) technologies, including the development of...more
Posted On - 2024-01-15


Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed

Food and Drug Administration
Computational fluid dynamics (CFD) has played a crucial role in providing an alternative bioequivalence (BE) approach for generic orally inhaled drug products (OIDPs), in addition to comparative...more
Posted On - 2024-01-15


Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Food and Drug Administration
The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to...more
Posted On - 2024-01-15


Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Food and Drug Administration
Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged...more
Posted On - 2024-01-15




Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional

Food and Drug Administration
This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the...more
Posted On - 2024-01-04


Critical Path Public Private Partnerships Clinical Trials Optional

Food and Drug Administration
The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement...more
Posted On - 2024-01-04




John Converse Townsend, a Forbes contributor, shares what can the private sector do for a social enterprise. He encourages social enterprises to reach out to corporations for help to scale up their businesses.






More Federal Domestic Assistance Programs


Environmental Education Grants | U.S. Nuclear Regulatory Commission Scholarship and
Fellowship Program
 | Food Safety and Security Monitoring Project | Community Food Projects | State Vital Statistics Improvement Program |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders